Clinical Trials Browser

NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

Phase 2/3 Completed

101 enrolled 13 charts

Gynecologic

Carcinoma, Uterine Cervical Neoplasms

NCT06227676 2024-04-12

NUTRITION; GYN

Phase 2/3 Completed

12 enrolled

Gynecologic

Dysmenorrhea, Menstruation Disturbances, Muscle Cramp, Ovarian Cysts, Polycystic Ovary Syndrome, Premenstrual Syndrome, Premenstrual Dysphoric Disorder

Clinical Trials

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

NUTRITION; GYN

iPocc

CONDESA

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

SaPPrOC

Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda

Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

ITIC

Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group